Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 1 | B0005 | IM / LA |
| FLU3 | INFLUENZA (SEASONAL) (FLUBLOK) | SANOFI PASTEUR | N/A | — | IM / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 3RE73 | IM / LA |
No adverse event reported. Reporting per Moderna after a temperature excursion, vaccine remained viable after the excursion per Moderna.
PTSD. acne vulgaris,
acne vulgaris, congenital talipes calcaneovalgus right foot, adjustment disorder, family history of clotting disorder
tretinoin, escitalopram, melatonin
No known allergies
N/A